NCT04860804View on ClinicalTrials.gov

A Comparison of Proprietary Formulations of Oral Ketamine + Aspirin and Oral Ketamine Alone for Musculoskeletal Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 22, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

December 31, 2021

Conditions
Pain
Interventions
DRUG

Aspirin and Ketamine

Drug: Proprietary oral formulation of 0.5mg/kg of ketamine + 324mg of aspirin

DRUG

Oral Ketamine

Proprietary oral formulation of 0.5mg/kg of ketamine

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

All Listed Sponsors
lead

Antonios Likourezos

OTHER